Lumora Therapeutics
Steering active substances through the body so they arrive where they work — for better survival odds and quality of life.
view profile
Current batch #3
Gliacure
A precision therapy aimed at the cancer stem cells that drive recurrence in the most aggressive brain tumours.
Gliacure targets the small population of tumour stem cells that survive standard glioblastoma treatment and seed relapse. The team holds a provisional patent on its lead compound class and is preparing an investor-ready data package for a seed round.
Since 2024OncologyBatch #3
More from batch #3
Cadence Mind
An AI companion that offers structured, clinically informed support during the long wait for a therapy place.
view profileVeristat Sensing
An implantable biosensor that measures glucose, lactate and core temperature continuously and in real time.
view profileTidewater Nutrition
AI-supported software that helps dietitians build, track and adjust nutrition plans for chronic-disease patients.
view profile